Risk and Prevention Study: Optimisation of the Preventive Strategies and Evaluation of the Efficacy of n-3 PUFA in Subjects at High Cardiovascular Risk.

Trial Profile

Risk and Prevention Study: Optimisation of the Preventive Strategies and Evaluation of the Efficacy of n-3 PUFA in Subjects at High Cardiovascular Risk.

Completed
Phase of Trial: Phase III

Latest Information Update: 09 May 2013

At a glance

  • Drugs Omega-3-acid ethyl esters (Primary) ; Olive oil
  • Indications Atherosclerosis; Cardiovascular disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 May 2013 Results published in the New England Journal of Medicine.
    • 17 Jan 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT00317707).
    • 17 Jan 2012 Official Title amended as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top